MPS Pharmaa informs about statement of investor complaints

11 Oct 2024 Evaluate
As per the requirements of Regulation 13(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, MPS Pharmaa has informed that it enclosed Statement of Investor Complaints for the quarter ended 30th September, 2024.

The above information is a part of company’s filings submitted to BSE.

MPS Pharmaa Share Price

3.18 0.00 (0.00%)
24-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1735.45
Dr. Reddys Lab 1144.05
Cipla 1441.70
Lupin 2026.50
Zydus Lifesciences 885.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...